두드러기 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상되며, 2029년까지 연평균 성장률(CAGR) 18.0%로 92억 3,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 만성 두드러기 환자 증가, 생물학적 치료법 채택 확대, 피부과 연구에 대한 투자 증가, 고급 알레르기 진단에 대한 접근성 확대, 맞춤형 의료 개발 등의 요인에 기인할 것으로 보입니다. 이 기간의 주요 동향으로는 AI를 활용한 진단 도구, 신규 생물학적 제제 개발, 맞춤형 면역치료의 발전, 웨어러블 피부 모니터링 기기, 알레르기 관리에 있어 원격의료의 활용 등을 꼽을 수 있습니다.
피부 질환에 대한 인식과 치료의 증가는 향후 몇 년 동안 두드러기 시장의 성장을 견인할 것으로 예상됩니다. 환경오염의 증가는 피부 알레르기 및 증상의 증가에 기여하고 있으며, 이는 더 나은 인식과 고급 치료에 대한 수요를 촉진하고 있습니다. 두드러기는 면역계 반응을 강조하고, 연구를 촉진하고, 진단 방법을 개선하고, 표적 치료를 발전시킴으로써 피부 질환에 대한 인식과 치료법을 향상시키는 데 중요한 역할을 하고 있습니다. 예를 들어, 2024년 2월 미국 비영리단체인 The Skin Cancer Foundation은 미국인 5명 중 1명이 70세까지 피부암에 걸리며, 미국에서는 시간당 2명 이상이 사망하고 있으며, 5회 이상 햇볕에 노출되면 흑색종 위험이 두 배로 증가하기 때문에 예방 조치가 시급합니다. 예방 대책이 시급한 것으로 강조되고 있습니다. 이처럼 피부질환에 대한 인식과 치료의 중요성이 높아지면서 두드러기 시장의 성장을 견인하고 있습니다.
이 시장의 주요 기업들은 비만세포의 활성화를 표적으로 삼아 만성 자연발생적 두드러기를 관리하는 비만세포 억제 항체와 같은 혁신적인 솔루션에 집중하고 있습니다. 비만세포 억제 항체는 특정 수용체 및 신호전달 경로를 억제하여 비만세포의 활성화 및 탈과립을 억제하여 알레르기 반응, 염증, 기타 비만세포가 관여하는 질환을 억제하는 단클론항체입니다. 예를 들어, 2024년 5월 미국 생명공학 기업 Allakos Inc.는 만성 자연발생적 두드러기(CSU) 치료제인 AK006의 임상 1상 시험 개시를 발표했습니다. 이 혁신적인 치료제는 IgE 의존성 및 IgE 비의존성 비만세포 활성화 경로를 모두 표적화하여 항히스타민제 및 기존 생물학적 제제 치료에 내성을 보이는 환자에서 더 높은 효과를 기대할 수 있습니다. 선택적으로 비만세포의 활성을 억제함으로써 CSU 치료에 있어 보다 포괄적이고 지속적인 솔루션을 제공하는 것을 목표로 하고 있으며, 두드러기 치료 및 면역치료 연구에 있어 중요한 한 걸음을 내딛는 것입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 두드러기 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 두드러기 시장 : 성장률 분석
- 세계의 두드러기 시장 실적 : 규모와 성장, 2019-2024년
- 세계의 두드러기 시장 예측 : 규모와 성장, 2024-2029년, 2034년
- 세계의 두드러기 전체 시장(TAM)
제6장 시장 세분화
- 세계의 두드러기 시장 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 급성 두드러기
- 만성 두드러기
- 세계의 두드러기 시장 : 약물 종류별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 항히스타민제
- 항염증제
- 항우울제
- 단클론항체
- 기타 약물 클래스
- 세계의 두드러기 시장 : 투여 경로별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 경구
- 비경구
- 기타 투여 경로
- 세계의 두드러기 시장 : 유통 채널별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 병원 약국
- 온라인 약국
- 소매 약국
- 세계의 두드러기 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 병원
- 홈케어
- 전문 클리닉
- 기타 최종사용자
- 세계의 두드러기 시장, 급성 두드러기 종류별 하위 세분화, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 알레르기 두드러기
- 감염성 두드러기
- 약물 유발성 두드러기
- 문의 두드러기
- 세계의 두드러기 시장, 만성 두드러기 종류별 하위 세분화, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 만성 자발성 두드러기(CSU)
- 만성 유도성 두드러기(CIndU)
제7장 지역별·국가별 분석
- 세계의 두드러기 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 세계의 두드러기 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 두드러기 시장 : 경쟁 구도
- 두드러기 시장 : 기업 개요
- Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
- Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- Teva Pharmaceutical Industries Ltd
- Sun Pharmaceutical Industries Ltd
- Incyte Corporation
- Kyowa Kirin Co. Ltd.
- Dr. Reddy's Laboratories Ltd
- Cipla Ltd.
- Amneal Pharmaceuticals Inc
- Glenmark Pharmaceuticals Ltd
- Torrent Pharmaceuticals
- Almirall S.A.
- Argenx SE
- BioCryst Pharmaceuticals Inc.
- Pharvaris NV
- Revolution Medicines Inc.
- Allakos
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 두드러기 시장 2029년 : 새로운 기회를 제공하는 국가
- 두드러기 시장 2029년 : 새로운 기회를 제공하는 부문
- 두드러기 시장 2029년 : 성장 전략
제36장 부록
ksm
Urticaria, commonly known as hives, is a skin condition characterized by red, itchy, and raised welts. It results from an allergic reaction, stress, or unknown triggers, leading to the release of histamine. The condition can be acute (lasting less than six weeks) or chronic (persisting for longer periods). Treatment typically includes antihistamines, avoiding triggers, and, in more severe cases, corticosteroids or immunotherapy.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main types of urticaria are acute urticaria and chronic urticaria. Acute urticaria is a sudden-onset condition that lasts less than six weeks, marked by red, itchy, and swollen welts, often triggered by allergic reactions, infections, medications, insect stings, or food allergens. Treatment options include drug classes such as antihistamines, anti-inflammatory medications, antidepressants, monoclonal antibodies, and others, administered through oral, parenteral, or other routes. These treatments are distributed via various channels, including hospital pharmacies, online pharmacies, and retail pharmacies, serving end users such as hospitals, homecare settings, specialty clinics, and others.
The Urticaria market research report is one of a series of new reports from The Business Research Company that provides Urticaria market statistics, including Urticaria industry global market size, regional shares, competitors with a Urticaria market share, detailed Urticaria market segments, market trends and opportunities, and any further data you may need to thrive in the Urticaria industry. This Urticaria market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The urticaria market size has grown rapidly in recent years. It will grow from$4.03 billion in 2024 to $4.77 billion in 2025 at a compound annual growth rate (CAGR) of 18.2%. The growth during the historic period can be attributed to factors such as the increasing prevalence of allergies, growing awareness of skin disorders, advancements in immunology and biologics, rising demand for antihistamines, and improvements in diagnostic techniques.
The urticaria market size is expected to see rapid growth in the next few years. It will grow to$9.23 billion in 2029 at a compound annual growth rate (CAGR) of 18.0%. The growth during the forecast period can be attributed to factors such as the rising cases of chronic urticaria, growing adoption of biologic therapies, increasing investments in dermatology research, expanding access to advanced allergy diagnostics, and the development of personalized medicine. Key trends during this period include AI-powered diagnostic tools, the development of novel biologics, advancements in personalized immunotherapy, wearable skin monitoring devices, and the use of telemedicine for allergy management.
The growing awareness and treatment of skin diseases are expected to drive the growth of the urticaria market in the coming years. Rising pollution levels contribute to an increase in skin allergies and conditions, boosting the demand for better awareness and advanced treatments. Urticaria plays a significant role in increasing skin disease awareness and treatment by highlighting immune system responses, promoting research, improving diagnostics, and advancing targeted therapies. For example, in February 2024, The Skin Cancer Foundation, a US-based nonprofit, reported that 1 in 5 Americans will develop skin cancer by age 70, with over 2 deaths occurring every hour in the U.S. This underscores the urgent need for preventive measures, as having five or more sunburns doubles the risk of melanoma. As such, the rising awareness and treatment of skin diseases are propelling the growth of the urticaria market.
Key players in the market are focusing on innovative solutions such as mast cell inhibitor antibodies to manage chronic spontaneous urticaria by targeting mast cell activation. Mast cell inhibitor antibodies are monoclonal antibodies that block the activation or degranulation of mast cells by inhibiting specific receptors or signaling pathways, thereby reducing allergic reactions, inflammation, and other mast cell-mediated disorders. For instance, in May 2024, Allakos Inc., a US-based biotechnology company, announced the initiation of a Phase 1 clinical trial for AK006, a treatment for chronic spontaneous urticaria (CSU). This innovative therapy targets both IgE-dependent and IgE-independent mast cell activation pathways, offering the potential for greater efficacy in patients who are resistant to antihistamines or prior biologic treatments. By selectively inhibiting mast cell activity through the Siglec-6 receptor, AK006 aims to provide a more comprehensive and lasting solution for CSU management, marking a significant step forward in urticaria treatment and immunotherapy research.
In April 2024, Incyte Corporation, a US-based biopharmaceutical company, acquired Escient Pharmaceuticals for $750 million. This acquisition aims to enhance Incyte's portfolio in inflammation and autoimmunity by advancing first-in-class oral Mas-related G protein-coupled receptor X2 (MRGPRX2) and Mas-related G protein-coupled receptor X4 (MRGPRX4) antagonists, which have the potential to improve treatments for chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), atopic dermatitis (AD), cholestatic pruritus, and other inflammatory disorders. Escient Pharmaceuticals, a US-based clinical-stage biotechnology company, focuses on developing small-molecule therapies for chronic urticaria and severe pruritus.
Major players in the urticaria market are Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Roche Holding AG, Viatris Inc., Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Incyte Corporation, Kyowa Kirin Co. Ltd., Dr. Reddy's Laboratories Ltd, Cipla Ltd., Amneal Pharmaceuticals Inc, Glenmark Pharmaceuticals Ltd, Torrent Pharmaceuticals, Almirall S.A., Argenx SE, BioCryst Pharmaceuticals Inc., Pharvaris NV, Revolution Medicines Inc., and Allakos.
North America was the largest region in the urticaria market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in urticaria report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the urticaria market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The urticaria market consists of sales of corticosteroids, biologics, immunosuppressants, leukotriene receptor antagonists, and topical anti-inflammatory creams or gels. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Urticaria Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on urticaria market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for urticaria ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The urticaria market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Acute Urticaria; Chronic Urticaria
- 2) By Drug Class: Antihistamines; Anti-inflammation Medications; Antidepressants; Monoclonal Antibodies; Other Drug Classes
- 3) By Route of Administration: Oral; Parenteral; Other Routes Of Administration
- 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
- 5) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
- Subsegments:
- 1) By Acute Urticaria: Allergic Urticaria; Infectious Urticaria; Drug-Induced Urticaria; Contact Urticaria
- 2) By Chronic Urticaria: Chronic Spontaneous Urticaria (CSU); Chronic Inducible Urticaria (CIndU)
- Companies Mentioned: Sanofi S.A.; Novartis AG; GlaxoSmithKline PLC; Roche Holding AG; Viatris Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Urticaria Market Characteristics
3. Urticaria Market Trends And Strategies
4. Urticaria Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Urticaria Growth Analysis And Strategic Analysis Framework
- 5.1. Global Urticaria PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Urticaria Market Growth Rate Analysis
- 5.4. Global Urticaria Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Urticaria Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Urticaria Total Addressable Market (TAM)
6. Urticaria Market Segmentation
- 6.1. Global Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Acute Urticaria
- Chronic Urticaria
- 6.2. Global Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antihistamines
- Anti-Inflammation Medications
- Antidepressants
- Monoclonal Antibodies
- Other Drug Classes
- 6.3. Global Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Parenteral
- Other Routes Of Administration
- 6.4. Global Urticaria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
- 6.5. Global Urticaria Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Homecare
- Specialty Clinics
- Other End-Users
- 6.6. Global Urticaria Market, Sub-Segmentation Of Acute Urticaria, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Allergic Urticaria
- Infectious Urticaria
- Drug-Induced Urticaria
- Contact Urticaria
- 6.7. Global Urticaria Market, Sub-Segmentation Of Chronic Urticaria, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chronic Spontaneous Urticaria (CSU)
- Chronic Inducible Urticaria (CIndU)
7. Urticaria Market Regional And Country Analysis
- 7.1. Global Urticaria Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Urticaria Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Urticaria Market
- 8.1. Asia-Pacific Urticaria Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Urticaria Market
- 9.1. China Urticaria Market Overview
- 9.2. China Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Urticaria Market
- 10.1. India Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Urticaria Market
- 11.1. Japan Urticaria Market Overview
- 11.2. Japan Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Urticaria Market
- 12.1. Australia Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Urticaria Market
- 13.1. Indonesia Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Urticaria Market
- 14.1. South Korea Urticaria Market Overview
- 14.2. South Korea Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Urticaria Market
- 15.1. Western Europe Urticaria Market Overview
- 15.2. Western Europe Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Urticaria Market
- 16.1. UK Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Urticaria Market
- 17.1. Germany Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Urticaria Market
- 18.1. France Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Urticaria Market
- 19.1. Italy Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Urticaria Market
- 20.1. Spain Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Urticaria Market
- 21.1. Eastern Europe Urticaria Market Overview
- 21.2. Eastern Europe Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Urticaria Market
- 22.1. Russia Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Urticaria Market
- 23.1. North America Urticaria Market Overview
- 23.2. North America Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Urticaria Market
- 24.1. USA Urticaria Market Overview
- 24.2. USA Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Urticaria Market
- 25.1. Canada Urticaria Market Overview
- 25.2. Canada Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Urticaria Market
- 26.1. South America Urticaria Market Overview
- 26.2. South America Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Urticaria Market
- 27.1. Brazil Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Urticaria Market
- 28.1. Middle East Urticaria Market Overview
- 28.2. Middle East Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Urticaria Market
- 29.1. Africa Urticaria Market Overview
- 29.2. Africa Urticaria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Urticaria Market Competitive Landscape And Company Profiles
- 30.1. Urticaria Market Competitive Landscape
- 30.2. Urticaria Market Company Profiles
- 30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Urticaria Market Other Major And Innovative Companies
- 31.1. Teva Pharmaceutical Industries Ltd
- 31.2. Sun Pharmaceutical Industries Ltd
- 31.3. Incyte Corporation
- 31.4. Kyowa Kirin Co. Ltd.
- 31.5. Dr. Reddy's Laboratories Ltd
- 31.6. Cipla Ltd.
- 31.7. Amneal Pharmaceuticals Inc
- 31.8. Glenmark Pharmaceuticals Ltd
- 31.9. Torrent Pharmaceuticals
- 31.10. Almirall S.A.
- 31.11. Argenx SE
- 31.12. BioCryst Pharmaceuticals Inc.
- 31.13. Pharvaris NV
- 31.14. Revolution Medicines Inc.
- 31.15. Allakos
32. Global Urticaria Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Urticaria Market
34. Recent Developments In The Urticaria Market
35. Urticaria Market High Potential Countries, Segments and Strategies
- 35.1 Urticaria Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Urticaria Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Urticaria Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
- 250617_r35006_Urticaria_GMR_2025
